Risk factor
Poor trading liquidity
Profitability factor
Very strong margins and returns
About
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E
Target Price
The average target price of MEDI.OL is 319 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell